AVERITAS PHARMA
Live / Registered — Registered (as of 01 Oct 2024)
What this means for you
Registered since 01 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97978677
- Registration number
- 7525040
- Mark type
- Stylized text
- Filed
- 26 Apr 2022
- Published for opposition
- 28 Mar 2023
- Registered
- 01 Oct 2024
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, and neurological diseases and disorders
Owner
- Averitas Pharma, Inc., Morristown, NJ, US
- Averitas Pharma, Inc., Morristown, NJ, US
- Averitas Pharma, Inc., Morristown, NJ, US
Prior registrations
Prosecution history
- 01 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 28 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Aug 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 02 May 2024 — USE AMENDMENT FILED
- 13 Aug 2024 — DIVISIONAL PROCESSING COMPLETE
- 02 May 2024 — DIVISIONAL REQUEST RECEIVED
- 07 Aug 2024 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 07 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Aug 2024 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 11 Jun 2024 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 10 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2024 — TEAS STATEMENT OF USE RECEIVED